Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age [Phase 3]
Phase 3 trial update evaluating lot-to-lot consistency of a 21-valent pneumococcal conjugate vaccine in healthy infants starting at 2 months…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine [Phase 2]
Phase 2 dose-ranging study evaluating a 25-valent pneumococcal conjugate vaccine has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months
Pfizer's Prevnar 20 pneumococcal vaccine is being studied for safety in infants aged 2 to 6 months, and the trial is currently active but no…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study to Learn About How a New Pneumococcal Vaccine Works in Children [Phase 2]
Pfizer completed a Phase 2 trial in children evaluating a new pneumococcal vaccine.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults [Phase 1]
Pfizer completed a Phase 1 study evaluating the safety and potential efficacy of 20vPnC and 13vPnC pneumococcal vaccines in Chinese adults.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants [Phase 3]
Phase 3 safety and immunogenicity study of co-administering GSK Meningococcal Group B Vaccine with a 13-valent pneumococcal vaccine and rout…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 1]
This is a Phase 1b clinical trial evaluating the safety and immunogenicity of a 13-valent pneumococcal polysaccharide conjugate vaccine (PCV…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Clinical Trial of PCV24 in Children Aged 2-17 Years [Phase 1]
Phase 1 trial of PCV24 in children aged 2-17 years has completed, assessing safety and initial dosing for pneumococcal disease. The study is…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years [Phase 1]
Phase I study of the pneumococcal conjugate vaccine PCV24 in children aged 2 months to 17 years is listed as active but not recruiting, spon…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 2]
Phase II trial of a 24-valent pneumococcal polysaccharide-conjugate vaccine is underway, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan [Phase 3]
Phase 3 trial evaluating the safety and immunogenicity of the 20vPnC vaccine in infants in India and Taiwan has completed, describing safety…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand [Phase 3]
Phase 3 study evaluating the DTwP-HepB-Hib-IPV (SHAN6) vaccine administered with routine vaccines in healthy infants and toddlers in Thailan…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants [Phase 2]
A Phase 2 trial evaluating safety, tolerability, and immunogenicity of VAX-24 in healthy infants has completed. The results assess the vacci…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study to Learn About How a New Pneumococcal Vaccine Works in Infants [Phase 2]
Pfizer is conducting a Phase 2 study to evaluate how a new pneumococcal vaccine works in infants; the study is currently ACTIVE_NOT_RECRUITI…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
This clinical trial update reports the completion of a study evaluating 2+1 versus 3+0 PCV13 vaccination schedules and their effect on nasop…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults [Phase 1, Phase 2]
A Phase 1/2 safety, tolerability, and immunogenicity study of VAX-31 in adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Pneumonia Vaccine Education Intervention Study [NA]
Geisinger Clinic completed a clinical trial evaluating an education intervention related to pneumonia and pneumococcal vaccination.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting [Phase 3]
Phase 3 trial evaluating pneumococcal vaccination in HIV patients, comparing conjugate vaccine to boosting with a polysaccharide vaccine, wi…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers [Phase 2]
Pfizer completed a Phase 2 trial evaluating a monovalent pneumococcal conjugate vaccine candidate in healthy toddlers; results have been pos…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Clinical Trial of PCV24 in Adults [Phase 1]
Phase 1 clinical trial of PCV24 in adults has completed, with the sponsor reporting the study status as completed.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15 [Phase 4]
Phase 4 clinical trial update indicates recruitment is ongoing to evaluate protection offered by the PCV15 pneumococcal vaccine against pneu…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: PCV13 + Hepatitis A Vaccine for Adults [Phase 4]
A Phase 4 trial completed, assessing immune responses to Prevnar 13 and a Hepatitis A vaccine in adults. The study measured immune response …
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Trial of Simplified Pneumococcal Vaccination in Vietnam II [Phase 2, Phase 3]
A Phase 2/3 trial evaluating a simplified pneumococcal vaccination schedule in Vietnam has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years) [Phase 1]
Phase 1 study in healthy adults (19-49) evaluating safety and immunogenicity of a pneumococcal conjugate vaccine candidate developed by Sano…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…